Non‐coding RNAs in cancer immunotherapy: Predictive biomarkers and targets
Background To date, standardising clinical predictive biomarkers for assessing the response
to immunotherapy remains challenging due to variations in personal genetic signatures …
to immunotherapy remains challenging due to variations in personal genetic signatures …
Non‐coding RNAs in cancer immunotherapy: Predictive biomarkers and targets
M Alahdal, E Elkord - Clinical and Translational …, 2023 - salford-repository.worktribe.com
Background: To date, standardising clinical predictive biomarkers for assessing the
response to immunotherapy remains challenging due to variations in personal genetic …
response to immunotherapy remains challenging due to variations in personal genetic …
Non-coding RNAs in cancer immunotherapy: Predictive biomarkers and targets
M Alahdal, E Elkord - Clinical and Translational Medicine, 2023 - scholar.xjtlu.edu.cn
Non-coding RNAs in cancer immunotherapy: Predictive biomarkers and targets — Xi'an
Jiaotong-Liverpool University Skip to main navigation Skip to search Skip to main content Xi'an …
Jiaotong-Liverpool University Skip to main navigation Skip to search Skip to main content Xi'an …
[PDF][PDF] Non-coding RNAs in cancer immunotherapy: Predictive biomarkers and targets
M Alahdal, E Elkord - 2023 - researchgate.net
Background: To date, standardising clinical predictive biomarkers for assessing the
response to immunotherapy remains challenging due to variations in personal genetic …
response to immunotherapy remains challenging due to variations in personal genetic …
Non‐coding RNAs in cancer immunotherapy: Predictive biomarkers and targets.
M Alahdal, E Elkord - Clinical & Translational Medicine, 2023 - search.ebscohost.com
Background: To date, standardising clinical predictive biomarkers for assessing the
response to immunotherapy remains challenging due to variations in personal genetic …
response to immunotherapy remains challenging due to variations in personal genetic …
Non-coding RNAs in cancer immunotherapy: Predictive biomarkers and targets
M Alahdal, E Elkord - Clinical and Translational Medicine, 2023 - search.proquest.com
Non‐coding RNAs in cancer immunotherapy: Predictive biomarkers and targets Page
1 Received: 3 July 2023 Revised: 6 September 2023 Accepted: 10 September 2023 DOI …
1 Received: 3 July 2023 Revised: 6 September 2023 Accepted: 10 September 2023 DOI …
Non-coding RNAs in cancer immunotherapy: Predictive biomarkers and targets.
M Alahdal, E Elkord - Clinical and Translational Medicine, 2023 - europepmc.org
Non-coding RNAs in cancer immunotherapy: Predictive biomarkers and targets. - Abstract -
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …
Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About Tools …
[HTML][HTML] Non‐coding RNAs in cancer immunotherapy: Predictive biomarkers and targets
M Alahdal, E Elkord - Clinical and Translational Medicine, 2023 - ncbi.nlm.nih.gov
Non‐coding RNAs in cancer immunotherapy: Predictive biomarkers and targets - PMC Back
to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …
to Top Skip to main content NIH NLM Logo Access keys NCBI Homepage MyNCBI Homepage …
Non-coding RNAs in cancer immunotherapy: Predictive biomarkers and targets
M Alahdal, E Elkord - Clinical and translational medicine, 2023 - pubmed.ncbi.nlm.nih.gov
Background To date, standardising clinical predictive biomarkers for assessing the response
to immunotherapy remains challenging due to variations in personal genetic signatures …
to immunotherapy remains challenging due to variations in personal genetic signatures …
[PDF][PDF] Non-coding RNAs in cancer immunotherapy: Predictive biomarkers and targets
M Alahdal, E Elkord - 2023 - salford-repository.worktribe.com